veopoz(Pozelimab)Medication DetailsRegeneron Pharmaceuticals, Inc.Usage: VEOPOZ is indicated for treating adult and pediatric patients aged 1 year and older with CD55-deficient protein-losing enteropathy (PLE), also referred to as CHAPLE disease.Medication DetailsDrug Interactions